{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:52:07Z","timestamp":1770724327610,"version":"3.49.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.critrevonc.2023.104110","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T11:54:46Z","timestamp":1693396486000},"page":"104110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Radiotherapy of high-grade gliomas: dealing with a stalemate"],"prefix":"10.1016","volume":"190","author":[{"given":"Guido","family":"Frosina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2023.104110_bib1","doi-asserted-by":"crossref","unstructured":"Adam, J.F., Balosso, J., Bayat, S., Berkvens, P., Berruyer, G., Br\u00e4uer-Krisch, E., Brochard, T., Chamel, G., Desagneaux, A., Drevon-Gaud, R., Eling, L., Est\u00e8ve, F., Flandin, I., Gaudin, M., Giraud, J.Y., Giraud, L., Gonzalez, H., Kefs, S., Keshmiri, S.,. Serduc, R. (2022). Toward Neuro-oncologic Clinical Trials of High-Dose-Rate Synchrotron Microbeam Radiation Therapy: First Treatment of a Spontaneous Canine Brain Tumor. International Journal of Radiation Oncology, Biology, Physics, S0360\u20133016(22)00335\u20132 [pii].","DOI":"10.1016\/j.ijrobp.2022.04.022"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104110_bib2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/WCO.0000000000000994","article-title":"Cancer stem cells in gliomas: evolving concepts and therapeutic implications","volume":"34","author":"Alcantara Llaguno","year":"2021","journal-title":"Curr. Opin. Neurol."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104110_bib3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41571-019-0177-5","article-title":"Challenges to curing primary brain tumours","volume":"16","author":"Aldape","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104110_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100779","article-title":"Myeloperoxidase exerts anti-tumor activity in glioma after radiotherapy","volume":"26","author":"Ali","year":"2022","journal-title":"Neoplasia"},{"issue":"354","key":"10.1016\/j.critrevonc.2023.104110_bib5","doi-asserted-by":"crossref","first-page":"354re3","DOI":"10.1126\/scitranslmed.aaf6853","article-title":"Origin of the U87MG glioma cell line: good news and bad news","volume":"8","author":"Allen","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104110_bib6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41417-021-00324-6","article-title":"Radiation enhances the delivery of antisense oligonucleotides and improves chemo-radiation efficacy in brain tumor xenografts","volume":"29","author":"Ambady","year":"2022","journal-title":"Cancer Gene Ther."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104110_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.32074\/1591-951X-823","article-title":"Adult type diffuse gliomas in the new 2021 WHO classification","volume":"114","author":"Antonelli","year":"2022","journal-title":"Pathologica"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104110_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11060-022-04026-3","article-title":"Brachytherapy for central nervous system tumors","volume":"158","author":"Bander","year":"2022","journal-title":"J. Neuro-Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104110_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10555-021-09997-9","article-title":"Glioma: molecular signature and crossroads with tumor microenvironment","volume":"41","author":"Barthel","year":"2022","journal-title":"Cancer Metastas. Rev."},{"key":"10.1016\/j.critrevonc.2023.104110_bib10","first-page":"873","article-title":"DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis","volume":"198","author":"Bernhardt","year":"2022"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104110_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1667\/RADE-21-00107.1","article-title":"Meloxicam can potentiate the therapeutic effects of synchrotron microbeam radiation therapy on high-grade glioma bearing rats","volume":"197","author":"Bouchet","year":"2022","journal-title":"Radiat. Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104110_bib12","article-title":"Sequential diffusion tensor imaging and magnetic resonance spectroscopy in patients undergoing reirradiation for progressive diffuse intrinsic pontine glioma","volume":"7","author":"Bronk","year":"2021","journal-title":"Adv. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104110_bib13","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1038\/s41598-020-63158-6","article-title":"Post-operative radiation therapy to the surgical cavity with standard fractionation in patients with brain metastases","volume":"10","author":"Byrne","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104110_bib14","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1158\/1078-0432.CCR-21-0947","article-title":"Long-acting recombinant human interleukin-7, NT-I7, increases cytotoxic CD8 T cells and enhances survival in mouse glioma models","volume":"28","author":"Campian","year":"2022","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104110_bib15","first-page":"744","article-title":"Glioblastoma - treatment and obstacles","volume":"27","author":"Cantidio","year":"2022","journal-title":"Rep. Pract. Oncol. Radiother. J. Gt. Cancer Cent. Pozn. Pol. Soc. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104110_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120207","article-title":"Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy","volume":"436","author":"Chanez","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.critrevonc.2023.104110_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.17458","article-title":"Annexin-1 is an oncogene in glioblastoma and causes tumour immune escape through the indirect upregulation of interleukin-8","author":"Chen","year":"2022","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104110_bib18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ijrobp.2021.09.047","article-title":"Radiosensitizing the vasculature of primary brainstem gliomas fails to improve tumor response to radiation therapy","volume":"112","author":"Deland","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2023.104110_bib19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jpsychires.2022.03.058","article-title":"Effects of two types of exercise training on psychological well-being, sleep and physical fitness in patients with high-grade glioma (WHO III and IV)","volume":"151","author":"Eisenhut","year":"2022","journal-title":"J. Psychiatr. Res."},{"issue":"16","key":"10.1016\/j.critrevonc.2023.104110_bib20","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.2217\/fon-2021-1455","article-title":"Palliative and end-of-life symptoms management for children with diffuse intrinsic pontine glioma","volume":"18","author":"Elhemaly","year":"2022","journal-title":"Future Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104110_bib21","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/jnr.25030","article-title":"Improving control of high-grade glioma by ultra-hyper-fractionated radiotherapy","volume":"100","author":"Frosina","year":"2022","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104110_bib22","doi-asserted-by":"crossref","first-page":"14191-w","DOI":"10.1038\/s41598-018-32578-w","article-title":"Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1]","volume":"8","author":"Frosina","year":"2018","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.104110_bib23","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1002\/jnr.24929","article-title":"Ultra-hyper-fractionated radiotherapy for high-grade gliomas","volume":"99","author":"Frosina","year":"2021","journal-title":"J. Neurosci. Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104110_bib24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jjco\/hyac004","article-title":"Boron neutron capture therapy and add-on bevacizumab in patients with recurrent malignant glioma","volume":"52","author":"Furuse","year":"2022","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104110_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101710","article-title":"Low-dose radiotherapy effects the progression of anti-tumor response","volume":"35","author":"Gao","year":"2023","journal-title":"Transl. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.104110_bib26","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/1878-0261.13200","article-title":"NOX4 regulates TGF\u03b2-induced proliferation and self-renewal in glioblastoma stem cells","volume":"16","author":"Garc\u00eda-G\u00f3mez","year":"2022","journal-title":"Mol. Oncol."},{"issue":"15","key":"10.1016\/j.critrevonc.2023.104110_bib27","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.3390\/ijms23158309","article-title":"LncRNA H19 impairs chemo and radiotherapy in tumorigenesis","volume":"23","author":"Garcia-Padilla","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104110_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030359","article-title":"The small molecule ephrin receptor inhibitor, GLPG1790, reduces renewal capabilities of cancer stem cells, showing anti-tumour efficacy on preclinical glioblastoma models","volume":"11","author":"Gravina","year":"2019","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104110_bib29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/cancers14020289","article-title":"ATX-101, a peptide targeting PCNA, has antitumor efficacy alone or in combination with radiotherapy in murine models of human glioblastoma","volume":"14","author":"Gravina","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104110_bib30","doi-asserted-by":"crossref","DOI":"10.2217\/cns-2022-0005","article-title":"A first-in-human phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma","volume":"11","author":"Groot","year":"2022","journal-title":"CNS Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104110_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142137","article-title":"Arginine deprivation alters microglial polarity and synergizes with radiation to eradicate non-arginine-auxotrophic glioblastoma tumors","volume":"132","author":"Hajji","year":"2022","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104110_bib32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.prro.2022.05.004","article-title":"Radiation therapy for IDH-mutant grade 2 and grade 3 diffuse glioma: an ASTRO clinical practice guideline","volume":"12","author":"Halasz","year":"2022","journal-title":"Pract. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104110_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.21873\/anticanres.15489","article-title":"Multiparametric MRI-guided hypofractionated intensity-modulated radiation therapy with simultaneous integrated boost for glioblastoma","volume":"42","author":"Hama","year":"2022","journal-title":"Anticancer Res."},{"key":"10.1016\/j.critrevonc.2023.104110_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2021.12.035","article-title":"Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma - How safe are protons","volume":"167","author":"Harrabi","year":"2022","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104110_bib35","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/WCO.0000000000001109","article-title":"The 2021 WHO classification of central nervous system tumors: what neurologists need to know","volume":"35","author":"Jamshidi","year":"2022","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.critrevonc.2023.104110_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2022.109038","article-title":"Apigenin sensitizes radiotherapy of mouse subcutaneous glioma through attenuations of cell stemness and DNA damage repair by inhibiting NF-\u03baB\/HIF-1\u03b1-mediated glycolysis","volume":"107","author":"Jia","year":"2022","journal-title":"J. Nutr. Biochem."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104110_bib37","doi-asserted-by":"crossref","first-page":"582","DOI":"10.4103\/njcp.njcp_1408_21","article-title":"Evaluation of IL-17A expressions in high-grade glial tumors receiving radiotherapy","volume":"25","author":"Karaca","year":"2022","journal-title":"Niger. J. Clin. Pract."},{"issue":"24","key":"10.1016\/j.critrevonc.2023.104110_bib38","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.3390\/cancers14246228","article-title":"Hyperthermia as a potential cornerstone of effective multimodality treatment with radiotherapy, cisplatin and PARP inhibitor in IDH1-mutated cancer cells","volume":"14","author":"Khurshed","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2023.104110_bib39","first-page":"1","article-title":"Preservation of language function by mapping the arcuate fasciculus using intraoperative corticocortical evoked potential under general anesthesia in glioma surgery","author":"Kim","year":"2022","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.critrevonc.2023.104110_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.943600","article-title":"Influences on cognitive outcomes in adult patients with gliomas: a systematic review","volume":"12","author":"Kirkman","year":"2022","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104110_bib41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.zemedi.2021.03.004","article-title":"Feasibility and clinical usefulness of modelling glioblastoma migration in adjuvant radiotherapy","volume":"32","author":"Knobe","year":"2022","journal-title":"Z. Fur Med. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104110_bib42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.21873\/invivo.12705","article-title":"Risk factors for sleep problems prior to radiochemotherapy for malignant gliomas","volume":"36","author":"Kopelke","year":"2022","journal-title":"Vivo"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104110_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13068","article-title":"Updates in the classification of ependymal neoplasms: the 2021 WHO classification and beyond","volume":"32","author":"Kresbach","year":"2022","journal-title":"Brain Pathol."},{"key":"10.1016\/j.critrevonc.2023.104110_bib44","first-page":"427","article-title":"Comparison of carbon ion and photon reirradiation for recurrent glioblastoma","volume":"198","author":"Lautenschlaeger","year":"2022"},{"issue":"9","key":"10.1016\/j.critrevonc.2023.104110_bib45","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.3390\/ijms23094743","article-title":"The long non-coding RNA HOXA-AS2 promotes proliferation of glioma stem cells and modulates their inflammation pathway mainly through post-transcriptional regulation","volume":"23","author":"Le Boiteux","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104110_bib46","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3390\/cancers14071627","article-title":"Advances in immunotherapy for the treatment of adult glioblastoma: overcoming chemical and physical barriers","volume":"14","author":"Lechpammer","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2023.104110_bib47","article-title":"Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma","volume":"4","author":"Lee","year":"2022","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.critrevonc.2023.104110_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112330","article-title":"GMT8 aptamer conjugated PEGylated Ag@Au core-shell nanoparticles as a novel radiosensitizer for targeted radiotherapy of glioma","volume":"211","author":"Li","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.critrevonc.2023.104110_bib49","article-title":"Long non-coding RNA LINC00152 in cancer: roles, mechanisms, and chemotherapy and radiotherapy resistance","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104110_bib50","article-title":"Identification of tumor antigens and immune subtypes of glioblastoma for mRNA vaccine development","volume":"13","author":"Lin","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2023.104110_bib51","article-title":"A multi-compartment model of glioma response to fractionated radiation therapy parameterized via time-resolved microscopy data","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104110_bib52","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.critrevonc.2023.104110_bib53","first-page":"2021","article-title":"Venetoclax cooperates with ionizing radiation to attenuate Diffuse Midline Glioma tumor growth","volume":"4002","author":"Madhavan","year":"2022","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. clincanres"},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104110_bib54","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/jpm12071050","article-title":"The current state of radiotherapy for pediatric brain tumors: an overview of post-radiotherapy neurocognitive decline and outcomes","volume":"12","author":"Major","year":"2022","journal-title":"J. Pers. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104110_bib55","doi-asserted-by":"crossref","first-page":"vdac168","DOI":"10.1093\/noajnl\/vdac168","article-title":"Adolescent and young adult glioma: systematic review of demographic, disease, and treatment influences on survival","volume":"4","author":"Malhotra","year":"2022","journal-title":"Neuro-Oncol. Adv."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104110_bib56","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.ijrobp.2007.11.071","article-title":"Low-dose hyper-radiosensitivity: past, present, and future","volume":"70","author":"Marples","year":"2008","journal-title":"Int. J. Radiat. Oncol., Biol., Phys."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.104110_bib57","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3390\/cancers14102393","article-title":"Safety and efficacy of Crizotinib in combination with temozolomide and radiotherapy in patients with newly diagnosed Glioblastoma: phase Ib GEINO 1402 trial","volume":"14","author":"Mart\u00ednez-Garc\u00eda","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2023.104110_bib58","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3389\/fonc.2019.00779","article-title":"Neural stem cells of the subventricular zone as the origin of human glioblastoma stem cells. therapeutic implications","volume":"9","author":"Matarredona","year":"2019","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104110_bib59","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3390\/biomedicines10071763","article-title":"Small molecules and immunotherapy agents for enhancing radiotherapy in Glioblastoma","volume":"10","author":"Matsui","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104110_bib60","doi-asserted-by":"crossref","first-page":"24-3","DOI":"10.1186\/s12883-021-02548-3","article-title":"Large tumour volume reduction of IDH-mutated anaplastic glioma involving the insular region following radiotherapy","volume":"22","author":"Metz","year":"2022","journal-title":"BMC Neurol."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104110_bib61","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.drudis.2021.12.016","article-title":"Experimental murine models of brainstem gliomas","volume":"27","author":"Ni","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104110_bib62","doi-asserted-by":"crossref","first-page":"85-x","DOI":"10.1186\/s13014-022-02054-x","article-title":"Assessment of therapeutic outcome and role of reirradiation in patients with radiation-induced glioma","volume":"17","author":"Ohno","year":"2022","journal-title":"Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104110_bib63","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s11060-022-04090-9","article-title":"Characteristics and therapeutic strategies of radiation-induced glioma: case series and comprehensive literature review","volume":"159","author":"Onishi","year":"2022","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.critrevonc.2023.104110_bib64","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ Clin. Res. Ed."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.104110_bib65","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.3390\/cancers14102507","article-title":"Gliomas infiltrating the corpus callosum: a systematic review of the literature","volume":"14","author":"Palmisciano","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2023.104110_bib66","doi-asserted-by":"crossref","DOI":"10.1007\/s11060-022-04050-3","article-title":"The role of cesium-131 brachytherapy in brain tumors: a scoping review of the literature and ongoing clinical trials","author":"Palmisciano","year":"2022","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.critrevonc.2023.104110_bib67","doi-asserted-by":"crossref","DOI":"10.1007\/s10143-022-01811-6","article-title":"Mini-craniotomy for intra-axial brain tumors: a comparison with conventional craniotomy in 306 patients harboring non-dural based lesions","author":"Paolini","year":"2022","journal-title":"Neurosurg. Rev."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104110_bib68","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.hoc.2021.08.003","article-title":"The evolving role of neurosurgical intervention for central nervous system tumors","volume":"36","author":"Peruzzi","year":"2022","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104110_bib69","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-0041-1735515","article-title":"IDH wild-type glioblastoma presenting with seizure: clinical specificity, and oncologic and surgical outcomes","volume":"83","author":"Pesce","year":"2022","journal-title":"J. Neurol. Surg. Part A Cent. Eur. Neurosurg."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104110_bib70","first-page":"3463","article-title":"Effects of low-dose naltrexone on quality of life in high-grade glioma patients: a placebo-controlled, double-blind randomized trial","volume":"30","author":"Peters","year":"2022","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104110_bib71","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jamaoncol.2021.5948","article-title":"Efficacy of treatment with armodafinil for cancer-related fatigue in patients with high-grade glioma: a phase 3 randomized clinical trial","volume":"8","author":"Porter","year":"2022","journal-title":"JAMA Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.104110_bib72","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.3390\/cancers14092304","article-title":"MEOX2 regulates the growth and survival of glioblastoma stem cells by modulating genes of the glycolytic pathway and response to hypoxia","volume":"14","author":"Proserpio","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104110_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110216","article-title":"ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization","volume":"38","author":"Qin","year":"2022","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104110_bib74","article-title":"Glioblastoma adjacent to radiosurgically treated arteriovenous malformation: a case report and review of the literature","volume":"14","author":"Richter","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104110_bib75","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/vco.12703","article-title":"Canine presumed glial brain tumours treated with radiotherapy: is there an inferior outcome in tumours contacting the subventricular zone","volume":"20","author":"Rohrer Bley","year":"2022","journal-title":"Vet. Comp. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104110_bib76","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1158\/1541-7786.MCR-08-0409","article-title":"Comparative analysis of DNA repair in stem and nonstem glioma cell cultures","volume":"7","author":"Ropolo","year":"2009","journal-title":"Mol. Cancer Res. MCR"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104110_bib77","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3171\/2020.11.JNS202715","article-title":"Asleep or awake motor mapping for resection of perirolandic glioma in the nondominant hemisphere? Development and validation of a multimodal score to tailor the surgical strategy","volume":"136","author":"Rossi","year":"2021","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.critrevonc.2023.104110_bib78","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.wneu.2021.08.140","article-title":"The extent of resection in gliomas-evidence-based recommendations on methodological aspects of research design","volume":"161","author":"Ruiz-Garcia","year":"2022","journal-title":"World Neurosurg."},{"key":"10.1016\/j.critrevonc.2023.104110_bib79","article-title":"Radiosensitization of high-grade gliomas through induced hyperthermia: review of clinical experience and the potential role of MR-guided focused ultrasound","author":"Schneider","year":"2019","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104110_bib80","first-page":"64","article-title":"Technical aspects of proton minibeam radiation therapy: minibeam generation and delivery","volume":"100","author":"Schneider","year":"2022","journal-title":"Phys. Med.: PM: Int. J. Devoted Appl. Phys. Med. Biol.: Off. J. Ital. Assoc. Biomed. Phys."},{"key":"10.1016\/j.critrevonc.2023.104110_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.748200","article-title":"Clinical studies on ultrafractionated chemoradiation: a systematic review","volume":"11","author":"Scirocco","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104110_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.857825","article-title":"Ultra-high-field MRI in the diagnosis and management of gliomas: a systematic review","volume":"13","author":"Shaffer","year":"2022","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104110_bib83","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/nop\/npy019","article-title":"Re-irradiation for recurrent high-grade gliomas: a systematic review and analysis of treatment technique with respect to survival and risk of radionecrosis","volume":"6","author":"Shanker","year":"2019","journal-title":"Neuro-Oncol. Pract."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104110_bib84","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s40291-022-00612-3","article-title":"Glioma 2021 WHO classification: the superiority of NGS over IHC in routine diagnostics","volume":"26","author":"\u015aledzi\u0144ska","year":"2022","journal-title":"Mol. Diagn. Ther."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.104110_bib85","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"New Engl. J. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104110_bib86","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/neuonc\/noab188","article-title":"Phase I\/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: a children's oncology group report","volume":"24","author":"Su","year":"2022","journal-title":"Neuro-Oncol."},{"issue":"15","key":"10.1016\/j.critrevonc.2023.104110_bib87","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.2217\/fon-2021-0963","article-title":"Multidomain and long-term cognitive evaluation in malignant glioma patients","volume":"18","author":"Tanzilli","year":"2022","journal-title":"Future Oncol."},{"key":"10.1016\/j.critrevonc.2023.104110_bib88","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noac044","article-title":"Quantifying the risk and dosimetric variables of symptomatic brainstem injury after proton beam radiation in pediatric brain tumors","author":"Upadhyay","year":"2022","journal-title":"Neuro-Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104110_bib89","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/CCO.0000000000000876","article-title":"Management of epilepsy in brain tumor patients","volume":"34","author":"van der Meer","year":"2022","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104110_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.04.038","article-title":"Glioma progression is shaped by genetic evolution and microenvironment interactions","author":"Varn","year":"2022","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104110_bib91","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3390\/cancers14051103","article-title":"PET imaging in neuro-oncology: an update and overview of a rapidly growing area","volume":"14","author":"Verger","year":"2022","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.critrevonc.2023.104110_bib92","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.3390\/cancers14102416","article-title":"Alterations in molecular profiles affecting glioblastoma resistance to radiochemotherapy: where does the good go","volume":"14","author":"Vilar","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104110_bib93","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00394-021-02666-1","article-title":"Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial","volume":"61","author":"Voss","year":"2022","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.critrevonc.2023.104110_bib94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-804280-9.00001-9","article-title":"Epidemiology of meningiomas","volume":"169","author":"Walsh","year":"2020","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104110_bib95","first-page":"397-5","article-title":"Effect of neoadjuvant iodine-125 brachytherapy upon resection of glioma","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2023.104110_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.962481","article-title":"Pathophysiological roles of integrins in gliomas from the perspective of glioma stem cells","volume":"10","author":"Wang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104110_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113077","article-title":"CRB2 enhances malignancy of glioblastoma via activation of the NF-\u03baB pathway","volume":"414","author":"Wang","year":"2022","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.critrevonc.2023.104110_bib98","doi-asserted-by":"crossref","DOI":"10.1111\/cns.13966","article-title":"Insights about circadian clock in glioma: from molecular pathways to therapeutic drugs","author":"Wang","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.critrevonc.2023.104110_bib99","doi-asserted-by":"crossref","first-page":"3477918","DOI":"10.1155\/2022\/3477918","article-title":"Efficacy and safety of temozolomide combined with radiotherapy in the treatment of malignant glioma","volume":"2022","author":"Wei","year":"2022","journal-title":"J. Healthc. Eng."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104110_bib100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104110_bib101","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202104055","article-title":"Pyruvate facilitates FACT-mediated \u03b3H2AX loading to chromatin and promotes the radiation resistance of glioblastoma","volume":"9","author":"Wu","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.critrevonc.2023.104110_bib102","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-022-02868-6","article-title":"RNF216 alleviates radiation-induced apoptosis and DNA damage through regulating ubiquitination-mediated degradation of p53 in glioblastoma","author":"Xie","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.104110_bib103","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1158\/1078-0432.CCR-20-0468","article-title":"Disruption of DNA repair and survival pathways through heat shock protein inhibition by onalespib to sensitize malignant gliomas to chemoradiation therapy","volume":"28","author":"Xu","year":"2022","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104110_bib104","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/biomedicines10020427","article-title":"Immunotherapeutic approaches for glioblastoma treatment","volume":"10","author":"Yaghi","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104110_bib105","doi-asserted-by":"crossref","first-page":"39-z","DOI":"10.1186\/s12943-022-01513-z","article-title":"Glioma targeted therapy: insight into future of molecular approaches","volume":"21","author":"Yang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2023.104110_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2022.01.054","article-title":"Hypofractionated radiotherapy for Diffuse Intrinsic Pontine Glioma (DIPG): a non-inferiority prospective randomized study including 253 children","author":"Zaghloul","year":"2022","journal-title":"Int. J. Radiat. Oncol., Biol., Phys."},{"key":"10.1016\/j.critrevonc.2023.104110_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101366","article-title":"Radiotherapy: brightness and darkness in the era of immunotherapy","volume":"19","author":"Zhai","year":"2022","journal-title":"Transl. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104110_bib108","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/cancers14040879","article-title":"What Does PET imaging bring to neuro-oncology in 2022? a review","volume":"14","author":"Zhang-Yin","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2023.104110_bib109","article-title":"Meningeal lymphatics regulate radiotherapy efficacy through modulating anti-tumor immunity","volume":"5","author":"Zhou","year":"2022","journal-title":"Cell Res."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823001981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823001981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:50:58Z","timestamp":1760903458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842823001981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":109,"alternative-id":["S1040842823001981"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104110","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy of high-grade gliomas: dealing with a stalemate","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104110"}}